154 related articles for article (PubMed ID: 17451201)
1. Antisense oligonucleotide targeting midkine suppresses in vivo angiogenesis.
Dai LC; Wang X; Yao X; Lu YL; Ping JL; He JF
World J Gastroenterol; 2007 Feb; 13(8):1208-13. PubMed ID: 17451201
[TBL] [Abstract][Full Text] [Related]
2. Enhanced therapeutic effects of combined chemotherapeutic drugs and midkine antisense oligonucleotides for hepatocellular carcinoma.
Dai LC; Wang X; Yao X; Lu YL; Ping JL; He JF
World J Gastroenterol; 2007 Apr; 13(13):1989-94. PubMed ID: 17461503
[TBL] [Abstract][Full Text] [Related]
3. Antisense oligonucleotides targeting midkine induced apoptosis and increased chemosensitivity in hepatocellular carcinoma cells.
Dai LC; Wang X; Yao X; Lu YL; Ping JL; He JF
Acta Pharmacol Sin; 2006 Dec; 27(12):1630-6. PubMed ID: 17112419
[TBL] [Abstract][Full Text] [Related]
4. Antisense oligonucleotides targeting midkine inhibit tumor growth in an in situ human hepatocellular carcinoma model.
Dai LC; Wang X; Yao X; Min LS; Ping JL; He JF
Acta Pharmacol Sin; 2007 Mar; 28(3):453-8. PubMed ID: 17303011
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo suppression of hepatocellular carcinoma growth by midkine-antisense oligonucleotide-loaded nanoparticles.
Dai LC; Yao X; Wang X; Niu SQ; Zhou LF; Fu FF; Yang SX; Ping JL
World J Gastroenterol; 2009 Apr; 15(16):1966-72. PubMed ID: 19399928
[TBL] [Abstract][Full Text] [Related]
6. Total alkaloids of Rubus alceifolius Poir shows anti-angiogenic activity in vivo and in vitro.
Zhao J; Lin W; Zhuang Q; Zhong X; Cao Z; Hong Z; Peng J
Integr Cancer Ther; 2014 Nov; 13(6):520-8. PubMed ID: 25148840
[TBL] [Abstract][Full Text] [Related]
7. Large scale preparation of midkine antisense oligonucleotides nanoliposomes by a cross-flow injection technique combined with ultrafiltration and high-pressure extrusion procedures.
Zhong J; Yao X; Li DL; Li LQ; Zhou LF; Huang HL; Min LS; Li J; Fu FF; Dai LC
Int J Pharm; 2013 Jan; 441(1-2):712-20. PubMed ID: 23142083
[TBL] [Abstract][Full Text] [Related]
8. In vivo inhibition of human hepatocellular carcinoma related angiogenesis by vinblastine and rapamycin.
Ribatti D; Nico B; Mangieri D; Longo V; Sansonno D; Vacca A; Dammacco F
Histol Histopathol; 2007 Mar; 22(3):285-9. PubMed ID: 17163402
[TBL] [Abstract][Full Text] [Related]
9. New Natural Pigment Fraction Isolated from Saw Palmetto: Potential for Adjuvant Therapy of Hepatocellular Carcinoma.
Tan HY; Wang N; Takahashi M; Feng Y; Li H; Feng Y
Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27527161
[TBL] [Abstract][Full Text] [Related]
10. The In Ovo Chick Chorioallantoic Membrane (CAM) Assay as an Efficient Xenograft Model of Hepatocellular Carcinoma.
Li M; Pathak RR; Lopez-Rivera E; Friedman SL; Aguirre-Ghiso JA; Sikora AG
J Vis Exp; 2015 Oct; (104):. PubMed ID: 26484588
[TBL] [Abstract][Full Text] [Related]
11. Midkine acts as proangiogenic cytokine in hypoxia-induced angiogenesis.
Weckbach LT; Groesser L; Borgolte J; Pagel JI; Pogoda F; Schymeinsky J; Müller-Höcker J; Shakibaei M; Muramatsu T; Deindl E; Walzog B
Am J Physiol Heart Circ Physiol; 2012 Aug; 303(4):H429-38. PubMed ID: 22707563
[TBL] [Abstract][Full Text] [Related]
12. Evodiamine exerts anti-tumor effects against hepatocellular carcinoma through inhibiting β-catenin-mediated angiogenesis.
Shi L; Yang F; Luo F; Liu Y; Zhang F; Zou M; Liu Q
Tumour Biol; 2016 Sep; 37(9):12791-12803. PubMed ID: 27449032
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of eukaryotic initiation factor 4E phosphorylation by cercosporamide selectively suppresses angiogenesis, growth and survival of human hepatocellular carcinoma.
Liu Y; Sun L; Su X; Guo S
Biomed Pharmacother; 2016 Dec; 84():237-243. PubMed ID: 27662474
[TBL] [Abstract][Full Text] [Related]
14. Dahuang Zhechong pill attenuates hepatic sinusoidal capillarization in liver cirrhosis and hepatocellular carcinoma rat model via the MK/integrin signaling pathway.
Fu C; Zhang Y; Xi WJ; Xu K; Meng F; Ma T; Li W; Wu L; Chen Z
J Ethnopharmacol; 2023 May; 308():116191. PubMed ID: 36731809
[TBL] [Abstract][Full Text] [Related]
15. Octreotide acts as an antitumor angiogenesis compound and suppresses tumor growth in nude mice bearing human hepatocellular carcinoma xenografts.
Jia WD; Xu GL; Xu RN; Sun HC; Wang L; Yu JH; Wang J; Li JS; Zhai ZM; Xue Q
J Cancer Res Clin Oncol; 2003 Jun; 129(6):327-34. PubMed ID: 12811549
[TBL] [Abstract][Full Text] [Related]
16. Rheum palmatum extract exerts anti-hepatocellular carcinoma effects by inhibiting signal transducer and activator of transcription 3 signaling.
Tan ZB; Fan HJ; Wu YT; Xie LP; Bi YM; Xu HL; Chen HM; Li J; Liu B; Zhou YC
J Ethnopharmacol; 2019 Mar; 232():62-72. PubMed ID: 30553869
[TBL] [Abstract][Full Text] [Related]
17. Regulation of angiogenesis by Id-1 through hypoxia-inducible factor-1alpha-mediated vascular endothelial growth factor up-regulation in hepatocellular carcinoma.
Lee TK; Poon RT; Yuen AP; Ling MT; Wang XH; Wong YC; Guan XY; Man K; Tang ZY; Fan ST
Clin Cancer Res; 2006 Dec; 12(23):6910-9. PubMed ID: 17145808
[TBL] [Abstract][Full Text] [Related]
18. Both antiangiogenesis- and angiogenesis-independent effects are responsible for hepatocellular carcinoma growth arrest by tyrosine kinase inhibitor PTK787/ZK222584.
Liu Y; Poon RT; Li Q; Kok TW; Lau C; Fan ST
Cancer Res; 2005 May; 65(9):3691-9. PubMed ID: 15867364
[TBL] [Abstract][Full Text] [Related]
19. Antiangiogenic activity of vitexicarpine in experimentally induced hepatocellular carcinoma: Impact on vascular endothelial growth factor pathway.
Hassoun SM; Abdel-Rahman N; Eladl EI; El-Shishtawy MM
Tumour Biol; 2017 Jun; 39(6):1010428317707376. PubMed ID: 28651490
[TBL] [Abstract][Full Text] [Related]
20. Antiangiogenic and Antitumor Activities of Aflibercept, a Soluble VEGF Receptor-1 and -2, in a Mouse Model of Hepatocellular Carcinoma.
Torimura T; Iwamoto H; Nakamura T; Abe M; Ikezono Y; Wada F; Sakaue T; Masuda H; Hashimoto O; Koga H; Ueno T; Yano H
Neoplasia; 2016 Jul; 18(7):413-24. PubMed ID: 27435924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
